Artesunate derived from traditional Chinese medicine induces DNA damage and repair

Cancer Research

Volumn 68, Issue 11, 2008, Pages 4347-4351

  Li, Paul C H ^a,d   Lam, Elena ^a   Roos, Wynand P ^a   Zdzienicka, Małgorzata Z ^c   Kaina, Bernd ^a   Efferth, Thomas ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d SIMON FRASER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; BRCA2 PROTEIN; DNA POLYMERASE; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG; XRCC2 PROTEIN; ARTEMISININ DERIVATIVE; DNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CHINESE MEDICINE; COMET ASSAY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; DOSE RESPONSE; DOUBLE STRANDED DNA BREAK; EXCISION REPAIR; GENOTOXICITY; HOMOLOGOUS RECOMBINATION; NECROSIS; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; ANIMAL; CELL LINE; CRICETULUS; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; HAMSTER; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; ARTEMISININS; BLOTTING, WESTERN; CELL LINE; COMET ASSAY; CRICETINAE; CRICETULUS; DNA; DNA DAMAGE; DNA REPAIR; FLUORESCENT ANTIBODY TECHNIQUE; MEDICINE, CHINESE TRADITIONAL;

EID: 49249122781     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-2970     Document Type: Article

References (23)

1. Klayman DL. Qinghaosu (artemisinin): an antimalarial drug from China. Science 1985;228:1049-55.
2. Efferth T. Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin - from bench to bedside. Planta Med 2007;73:299-309.
3. Woerdenbag HJ, Moskal TA, Pras N, et al. Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells. J Nat Prod 1993;56:849-56.
4. Efferth T, Rücker G, Falkenberg M et al. Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs. Arzneimittelforschung 1996;46:196-200.
5. Efferth T, Dunstan H, Sauerbreys A, Miyachi H, Chitambar CR. The antimalarial artesunate is also active against cancer. Int J Oncol 2001;18:767-73.
6. Efferth T, Sauerbrey A, Olbrich A, et al. Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol 2003;64:382-94.
7. Singh NP, Lai H. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci 2001;70:49-56.
8. Berman PA, Adams PA. Artemisinin enhances heme-catalyzed oxidation of lipid membranes. Free Radic Biol Med 1997;22:1283-8.
9. Meshnick SR, Yang YZ, Lima V, Huypers F, Kamchonwongpaisan S, Yuthavong Y. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob Agents Chemother 1993;37:1108-14.
10. Asawamahasakda W, Ittarat I, Pu YM, Ziffer H, Meshnick SR. Reaction of antimalarial endoperoxides with specific parasite proteins. Antimicrob Agents Chemother 1994;38:1854-8.
11. Eckstein-Ludwig U, Webb RJ, Van Goethem ID, et al. Artemisinins target the SERCA of Plasmodium falciparum. Nature 2003;424:957-61.
12. Efferth T, Briehl MM, Tome ME. Role of antioxidant genes for the activity of artesunate against tumor cells. Int J Oncol 2003;23:1231-5.
13. Efferth T, Benakis A, Romero MR, et al. Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic Biol Med 2004;27:998-1009.
14. Yang YZ, Little B, Meshnick SR. Alkylation proteins by artemisinin. Effect of heme, pH, and drug structure. Biochem Pharmacol 1994;48:569-73.
15. Dunkern TR, Kaina B. Cell proliferation and DNA breaks are involved in ultraviolet light-induced apoptosis in nucleotide excision repair-deficient Chinese hamster cells. Mol Biol Cell 2002;13:348-61.
16. Sobol RW, Prasad R, Evenski A, et al. The lyase activity of the DNA repair protein β-polymerase protects from DNA-damage-induced cytotoxicity. Nature 2000;405:807-10.
17. Briegert M, Kaina B. Human monocytes, but not dendritic cells derived from them, are defective in base excision repair and hypersensitive to methylating agents. Cancer Res 2007;67:26-31.
18. Kraakman-van der Zwet M, Overkamp WJ, van Lange RE, et al. Brca2 (XRCC11) deficiency results in radio-resistant DNA synthesis and a higher frequency of spontaneous deletions. Mol Cell Biol 2002;22:669-79.
19. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N; International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 2004;363:9-17.
20. Gordi T, Lepist EI. Artemisinin derivatives: toxic for laboratory animals, safe for humans? Toxicol Lett 2004;147:99-107.
21. Schmuck G, Roehrdanz E, Haynes RK, Kahl R. Neurotoxic mode of action of artemisinin. Antimicrob Agents Chemother 2002;46:821-7.
22. Efferth T, Volm M. Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate. In Vivo 2005;19:225-32.
23. Smith SL, Sadler CJ, Dodd CC, et al. The role of glutathione in the neurotoxicity of artemisinin derivatives in vitro . Biochem Pharmacol 2001;61:409-16.